Thromboembolic Concerns Raised After Evidence Points to High Risk of Adverse Events Caused by Popular Drugs According to AJMC.com, one popular drug frequently prescribed to people suffering from rheumatoid arthritis and another that treats myelofibrosis and polycythemia vera has been linked to life-threatening thromboembolic … [Read more...] about Fatalities Linked to Xeljanz and Jakafi

Drug Defect Lawyers Parker Waichman LLP Discuss Janus Kinase Inhibitors’ Link to Serious Illness and Death According to AJMC.com, a review of the database repository maintained by the U.S. Food and Drug Administration to record adverse effects attributed to medications and other therapies, commonly referred to as FAERS, suggests … [Read more...] about Xeljanz and Jakafi Linked to Fatalities